There was not a significant association between survival outcomes and other clinical factors, including the Eastern Cooperative Oncology Group (ECOG) performance status (PS), EGFR mutation status, metastasis, age, sex, histology and tumor stage (Supplementary Table 1). This evidence concerns the gene EGFR and neoplasm.